Basic Information
| RNALocate ID: | RLID:11000935 |
| RNA Symbol: | hsa-miR-33a-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-33a-5p |
| RNA ID: | miRBase:MIMAT0000091 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001394 | Cytoplasm | Adjacent normal tissue|GC tissue | 30943047 |
| RLID:01001395 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001396 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001397 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11000933 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000934 | Exosome | Brain tissue | 23382797 |
| RLID:11000936 | Microvesicle | Plasma | 23077538 |
| RLID-D:11000290 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine | |
| RLID-D:11001158 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-33a-5p | Splenic marginal zone lymphoma | MNDR-E-MI-41634 |
| MNDR | hsa-miR-33a-5p | Oral squamous cell carcinoma | MNDR-E-MI-41635 |
| MNDR | hsa-miR-33a-5p | Medulloblastoma | MNDR-E-MI-41636 |
| MNDR | hsa-miR-33a-5p | Lymphoma | MNDR-E-MI-41637 |
| MNDR | hsa-miR-33a-5p | Lymphoma non-hodgkin | MNDR-E-MI-41638 |
| MNDR | hsa-miR-33a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-41639 |
| MNDR | hsa-miR-33a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-41640 |
| MNDR | hsa-miR-33a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-41641 |
| MNDR | hsa-miR-33a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-41642 |
| MNDR | hsa-miR-33a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-41643 |
| MNDR | hsa-miR-33a-5p | Breast cancer luminal | MNDR-E-MI-41644 |
| MNDR | hsa-miR-33a-5p | Dermatomyositis | MNDR-E-MI-41645 |
| MNDR | hsa-miR-33a-5p | Prostate cancer | MNDR-E-MI-41646 |
| MNDR | hsa-miR-33a-5p | B-cell chronic lymphocytic leukemia | MNDR-E-MI-41647 |
| MNDR | hsa-miR-33a-5p | Gastric cancer | MNDR-E-MI-41648 |
| MNDR | hsa-miR-33a-5p | Gastric lymphoma | MNDR-E-MI-41649 |
| MNDR | hsa-miR-33a-5p | Alzheimer disease | MNDR-E-MI-41650 |
| MNDR | hsa-miR-33a-5p | Japanese encephalitis | MNDR-E-MI-41651 |
| MNDR | hsa-miR-33a-5p | Myotonic dystrophy | MNDR-E-MI-41652 |
| MNDR | hsa-miR-33a-5p | Head and neck cancer | MNDR-E-MI-41653 |
| MNDR | hsa-miR-33a-5p | Huntington disease | MNDR-E-MI-41654 |
| MNDR | hsa-miR-33a-5p | Chorea | MNDR-E-MI-41655 |
| MNDR | hsa-miR-33a-5p | Cardiovascular disease | MNDR-E-MI-41656 |
| MNDR | hsa-miR-33a-5p | Lung cancer | MNDR-E-MI-41657 |
| MNDR | hsa-miR-33a-5p | Parkinson disease | MNDR-E-MI-41658 |
| MNDR | hsa-miR-33a-5p | Basal-like breast cancer | MNDR-E-MI-41659 |
| MNDR | hsa-miR-33a-5p | Pancreatic cancer | MNDR-E-MI-41660 |
| MNDR | hsa-miR-33a-5p | Hepatitis C | MNDR-E-MI-41661 |
| MNDR | hsa-miR-33a-5p | Melanoma | MNDR-E-MI-41662 |
| MNDR | hsa-miR-33a-5p | Atherosclerosis | MNDR-E-MI-41663 |
| MNDR | hsa-miR-33a-5p | Rectum adenocarcinoma | MNDR-E-MI-41664 |
| MNDR | hsa-miR-33a-5p | Nephroblastoma | MNDR-E-MI-41665 |
| MNDR | hsa-miR-33a-5p | Colon cancer | MNDR-E-MI-41666 |
| MNDR | hsa-miR-33a-5p | Colon adenocarcinoma | MNDR-E-MI-41667 |
| MNDR | hsa-miR-33a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-41668 |
| MNDR | hsa-miR-33a-5p | Familial ovarian cancer | MNDR-E-MI-41669 |
| MNDR | hsa-miR-33a-5p | Prostate adenocarcinoma | MNDR-E-MI-41670 |
| MNDR | hsa-miR-33a-5p | Carcinoma ductal breast | MNDR-E-MI-41671 |
| MNDR | hsa-miR-33a-5p | Glioblastoma | MNDR-E-MI-41672 |
| MNDR | hsa-miR-33a-5p | Glioma | MNDR-E-MI-41673 |
| MNDR | hsa-miR-33a-5p | Hyperlipoproteinemia type iii | MNDR-E-MI-41674 |
| MNDR | hsa-miR-33a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-41675 |
| MNDR | hsa-miR-33a-5p | Osteosarcoma | MNDR-E-MI-41676 |
| MNDR | hsa-miR-33a-5p | Breast carcinoma | MNDR-E-MI-41677 |
| MNDR | hsa-miR-33a-5p | Uterine cancer | MNDR-E-MI-41678 |
| MNDR | hsa-miR-33a-5p | Cervical adenocarcinoma | MNDR-E-MI-41679 |
| MNDR | hsa-miR-33a-5p | Gastric adenocarcinoma | MNDR-E-MI-41680 |
| MNDR | hsa-miR-33a-5p | Cervical squamous cell carcinoma | MNDR-E-MI-41681 |
| MNDR | hsa-miR-33a-5p | Bone-invasive pituitary adenoma | MNDR-E-MI-41682 |
| MNDR | hsa-miR-33a-5p | Lung squamous cell carcinoma | MNDR-E-MI-41683 |
| MNDR | hsa-miR-33a-5p | Lung adenocarcinoma | MNDR-E-MI-41684 |
| MNDR | hsa-miR-33a-5p | Adrenocortical cancer | MNDR-E-MI-41685 |
| MNDR | hsa-miR-33a-5p | Bladder urothelial carcinoma | MNDR-E-MI-41686 |
| MNDR | hsa-miR-33a-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-41687 |
| MNDR | hsa-miR-33a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-41688 |
| MNDR | hsa-miR-33a-5p | Renal clear cell carcinoma | MNDR-E-MI-41689 |
| MNDR | hsa-miR-33a-5p | Esophageal cancer | MNDR-E-MI-41690 |
| MNDR | hsa-miR-33a-5p | Liver cirrhosis | MNDR-E-MI-41691 |
| MNDR | hsa-miR-33a-5p | Synovial sarcoma | MNDR-E-MI-41692 |
| MNDR | hsa-miR-33a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-41693 |
| MNDR | hsa-miR-33a-5p | Fibromyalgia | MNDR-E-MI-41694 |
| MNDR | hsa-miR-33a-5p | Breast invasive carcinoma | MNDR-E-MI-41695 |
| MNDR | hsa-miR-33a-5p | Hepatocellular carcinoma | MNDR-E-MI-41696 |
| MNDR | hsa-miR-33a-5p | Familiar ovarian carcinoma | MNDR-E-MI-41697 |
| MNDR | hsa-miR-33a-5p | B-cell lymphoma | MNDR-E-MI-41698 |
| MNDR | hsa-miR-33a-5p | T-cell leukemia | MNDR-E-MI-41699 |
| MNDR | hsa-miR-33a-5p | Malignant pleural mesothelioma | MNDR-E-MI-41700 |
| MNDR | hsa-miR-33a-5p | Barrett's adenocarcinoma | MNDR-E-MI-41701 |
| MNDR | hsa-miR-33a-5p | Hodgkin lymphoma | MNDR-E-MI-41702 |
| MNDR | hsa-miR-33a-5p | Burkitt lymphoma | MNDR-E-MI-41703 |
| MNDR | hsa-miR-33a-5p | Skin cutaneous melanoma | MNDR-E-MI-41704 |
| MNDR | hsa-miR-33a-5p | Skin melanoma | MNDR-E-MI-41705 |
| MNDR | hsa-miR-33a-5p | Acute myelogenous leukemia | MNDR-E-MI-41706 |
| MNDR | hsa-miR-33a-5p | Colorectal cancer | MNDR-E-MI-41707 |
| MNDR | hsa-miR-33a-5p | Multiple myeloma | MNDR-E-MI-41708 |
| MNDR | hsa-miR-33a-5p | Prostatic neoplasms | MNDR-E-MI-41709 |
| MNDR | hsa-miR-33a-5p | Epstein-barr virus infections | MNDR-E-MI-41710 |
| MNDR | hsa-miR-33a-5p | Stroke lacunar | MNDR-E-MI-41711 |
| MNDR | hsa-miR-33a-5p | Non-alcoholic fatty liver disease | MNDR-E-MI-41712 |
| MNDR | hsa-miR-33a-5p | Barrett's carcinogenesis | MNDR-E-MI-41713 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCA1 | Homo sapiens | RR00022115 |
TOP